课题基金 / 基金详情

项目摘要

项目成果

Jennifer Rubin Grandis的其他基金

相似基金

相关文献

中文摘要
翻译
我们在旧金山的加州大学建立了UCSF临床和转化科学研究所(CTSI), 弗朗西斯科(加州大学旧金山分校)在2006年加快研究的步伐,改善公众的健康。CTSI的总体使命是改善和改造临床和转化研究基础设施,并在UCSF和我们的合作机构培训。在下一个资助期,我们的目标是利用我们开发的大量知识,技能和基础设施,进一步加快UCSF的研究步伐,将我们的成功出口到其他机构,并通过以下目标创建旨在改善我们自己和其他社区健康的举措: 具体目标1:加强加州大学旧金山分校CTSI的高度成功的活动,包括开发新的 在培训、基础设施/服务和宣传/文化变革领域的举措:a)培训:提供 为各级学生提供的课程,跨越各种环境,包括改善的所有阶段, 医疗保健; B)基础设施/服务:扩大服务和工具,以临床和转化研究人员在加州大学旧金山分校,我们的合作伙伴机构,并在更广泛的区域,国家和全球社区;和,c)宣传/文化变革:培养沟通,鼓励合作,促进创新,并催化临床和转化研究的成功进行;支持多元化的教师;增加社区的参与和研究对社区需求的响应;改变学术文化,促进多学科的合作工作。 具体目标2:利用知识、技能和基础设施, 多个CTSI计划在第一个资助期,以加速临床和转化研究及其对 健康,远远超出了在UCSF CTSI合作的机构。新举措将:a)使当地公众 健康和慈善团体与CTSI合作,改善旧金山弗朗西斯科湾区社区的健康状况 通过一系列针对高影响条件的健康改善项目; B)创建一个示范系统, 加快临床和转化研究的步伐,包括简化监管,开发参与者招募服务,提供研究管理,并将研究服务直接纳入社区实践;以及,c)通过设定具有挑战性的目标和跟踪公共仪表板上的绩效指标,提高CTSI内部研究管理的绩效,透明度和问责制。 这些目标将通过协调我们10个项目内部和之间的活动来实现,得到经过验证的治理模式的支持,并与机构和社区领导层建立密切联系。我们的最终目标是更快地为更多人带来更好的健康。
英文摘要
We established the UCSF Clinical and Translational Science Institute (CTSI) at the University of California, San Francisco (UCSF) in 2006 to accelerate the pace of research that improves the health ofthe public. The overall mission of CTSI has been to improve and transform clinical and translational research infrastructure and training at UCSF and our partner institutions. In the next funding period we aim to use the substantial knowledge, skills, and infrastructure that we have developed to further accelerate the pace of research at UCSF, to export our successes to other institutions, and to create initiatives aimed at improving the health of our own and other communities, through the following aims: SPECIFIC AIM 1: To enhance the highly successful activities of the UCSF CTSI, including the development of new initiatives in the areas of Training, Jnfrastructure/Services, and Advocacy/Culture Change: a) Training: to provide programs for students at all levels, across a spectrum of settings, and including all phases of the improvement of healthcare; b) Infrastructure/Services: to expand services and tools to clinical and translational investigators at UCSF, our partner institutions, and within the broader regional, national, and global communities; and, c) Advocacy/Culture Change: to nurture communication, encourage collaboration, foster innovation, and catalyze the successful conduct of clinical and translational research; to support a diverse faculty; to increase involvement ofthe community and the responsive of research to its needs; and change the academic culture to promote multidisciplinary, collaborative work. SPECIFIC AIM 2: To develop crosscutting initiatives using the knowledge, skills, and infrastructure developed by multiple CTSI programs in the first funding period to accelerate clinical and translational research and its impact on health, well beyond the institutions collaborating in the UCSF CTSI. New initiatives will: a) Bring together local public health and philanthropic groups to work with CTSI to improve the health of the San Francisco Bay Area community through a series of health improvement projects directed at high impact conditions; b) create a model system to accelerate the pace of clinical and translational research that includes streamlining regulation, developing participant recruitment services, providing research management, and bringing research services directly into community practices; and, c) improve the performance, transparency and accountability of research administration within and jeyond CTSI by setting challenging goals and tracking performance metrics on public dashboards. These aims will be achieved by orchestration of activities occurring within and between our 10 programs, supported by a proven governance model, and with strong ties to institutional and community leadership. Our ultimate goal is to bring better health to more people more quickly.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/pace.12962
发表时间: 2016-12
期刊: Pacing and clinical electrophysiology : PACE
影响因子: --
作者: [Nguyen KT, Gladstone RA, Dukes JW, Nazer B, Vittinghoff E, Badhwar N, Vedantham V, Gerstenfeld EP, Lee BK, Lee RJ, Tseng ZH, Olgin JE, Scheinman MM, Marcus GM]
通讯作者: Marcus GM
DOI: 10.1097/ta.0000000000001313
发表时间: 2017-02
期刊: The journal of trauma and acute care surgery
影响因子: --
作者: [Kunitake RC, Howard BM, Kornblith LZ, Christie SA, Conroy AS, Cohen MJ, Callcut RA]
通讯作者: Callcut RA
DOI: 10.1136/tsaco-2017-000131
发表时间: 2018
期刊: Trauma surgery & acute care open
影响因子: 2
作者: [Kunitake RC, Kornblith LZ, Cohen MJ, Callcut RA]
通讯作者: Callcut RA
Increasing Rates of Surgical Management of Multilevel Spinal Curvature in Elderly Patients.
老年患者多级脊柱弯曲的手术治疗率不断提高。
DOI: 10.1016/j.jspd.2016.03.005
发表时间: 2016
期刊: Spine deformity
影响因子: 1.6
作者: [Sing,DavidC, Khanna,Ryan, Shaw,JeremyD, Metz,LionelN, Burch,Shane, Berven,SigurdH]
通讯作者: Berven,SigurdH
共 7 条
    Targeting STAT3 to enhance anti-tumor immunity
    Targeting STAT3 to enhance anti-tumor immunity
    Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy
    Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy
    海外基金